AEON Biopharma (AEON) Long-Term Investments (2021 - 2023)
AEON Biopharma (AEON) posted Long-Term Investments of $21.2 million for Q2 2023, up 0.57% sequentially from $21.1 million in Q1 2023, and down 92.33% YoY from $276.3 million in Q2 2022.
AEON Biopharma (AEON) Long-Term Investments (2021 - 2023) Analysis & Trends
AEON Biopharma has reported Long-Term Investments for 3 years, with the latest figure at $21.2 million in Q2 2023.
- Quarterly Long-Term Investments fell 92.33% year-over-year to $21.2 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $21.2 million (down 92.33% YoY) and the FY2022 annual result came in at $279.4 million, up 1.2% from the prior year.
- Long-Term Investments rose to $21.2 million in Q2 2023 per AEON's latest filing, from $21.1 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $279.4 million in Q4 2022 and troughed at $21.1 million in Q1 2023.
- A 3-year average of $225.5 million and a median of $276.1 million in 2021 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2022 and 2023: Long-Term Investments increased 1.2% in 2022, then slumped 92.37% in 2023.
- Over 3 years, Long-Term Investments stood at $276.1 million in 2021, then increased by 1.2% to $279.4 million in 2022, then plunged by 92.41% to $21.2 million in 2023.
- According to Business Quant data, Long-Term Investments over the past three periods registered $21.2 million, $21.1 million, and $279.4 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 21.19 Mn |
| Mar 31, 2023 | 21.07 Mn |
| Dec 31, 2022 | 279.38 Mn |
| Sep 30, 2022 | 277.16 Mn |
| Jun 30, 2022 | 276.27 Mn |
| Mar 31, 2022 | 276.13 Mn |
| Dec 31, 2021 | 276.08 Mn |
| Sep 30, 2021 | 276.06 Mn |
| Jun 30, 2021 | 276.04 Mn |
| Mar 31, 2021 | 276.01 Mn |